Over the last 7 days, the United States market has experienced a 1.4% decline, yet it remains up by 16% over the past year with earnings expected to grow by 18% annually. In this fluctuating environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
VSE (VSEC)	$197.08	$382.81	48.5%
Upstart Holdings (UPST)	$28.64	$56.58	49.4%
Rayonier (RYN)	$21.53	$43.05	50%
Q2 Holdings (QTWO)	$52.86	$103.93	49.1%
Mobileye Global (MBLY)	$8.78	$16.86	47.9%
Hims & Hers Health (HIMS)	$31.68	$61.59	48.6%
ConnectOne Bancorp (CNOB)	$33.00	$65.58	49.7%
Boeing (BA)	$208.65	$411.65	49.3%
Beacon Financial (BBT)	$30.18	$59.66	49.4%
Alkami Technology (ALKT)	$16.48	$32.07	48.6%

We're going to check out a few of the best picks from our screener tool.

Ligand Pharmaceuticals (LGND)

Overview: Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that develops and licenses biopharmaceutical assets globally, with a market cap of approximately $6.05 billion.

Operations: The company's revenue primarily comes from the development and licensing of biopharmaceutical assets, generating $274.48 million.

Estimated Discount To Fair Value: 28.8%

Ligand Pharmaceuticals is trading at US$304.26, below its estimated future cash flow value of US$427.29, suggesting undervaluation based on discounted cash flows. Despite dropping from several indices, its earnings and revenue are forecast to grow faster than the broader U.S. market, with earnings projected to rise 19% annually. Recent financial maneuvers include a US$625 million zero-coupon note offering and a shelf registration filing for up to $1 billion in securities.

Legence (LGN)

Overview: Legence Corp. offers engineering, installation, and maintenance services for mission-critical systems in U.S. buildings, with a market cap of approximately $7.84 billion.

Operations: The company's revenue is primarily derived from its Installation & Maintenance segment, which generated $2.34 billion, followed by the Engineering & Consulting segment with $746.65 million.

Estimated Discount To Fair Value: 20.8%

Legence is trading at US$72.87, below its estimated future cash flow value of US$91.99, highlighting potential undervaluation. Despite being dropped from multiple indices, it has revised its revenue guidance upward to US$4.1 billion-US$4.3 billion for 2026 and reported a significant turnaround in profitability with net income of US$16.09 million in Q1 2026 compared to a loss the previous year. However, interest payments remain inadequately covered by earnings.

Belden (BDC)

Overview: Belden Inc. offers connection solutions to enhance data infrastructure and has a market cap of approximately $3.97 billion.

Operations: The company's revenue segments include Industrial Solutions, generating $1.36 billion, and Enterprise Solutions, contributing $1.31 billion.

Estimated Discount To Fair Value: 36.7%

Belden is trading at US$105.54, significantly below its estimated future cash flow value of US$166.64, indicating potential undervaluation. Earnings are projected to grow 24.1% annually over the next three years, outpacing the broader U.S. market growth rate of 17.7%. Despite high debt levels, Belden's strategic alliances and product innovations in industrial connectivity and edge analytics enhance its operational capabilities and market position, supporting long-term revenue growth expectations above the industry average.

Taking Advantage

• Click this link to deep-dive into the 148 companies within our Undervalued US Stocks Based On Cash Flows screener.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.